<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00376493</url>
  </required_header>
  <id_info>
    <org_study_id>APA 05-452</org_study_id>
    <nct_id>NCT00376493</nct_id>
  </id_info>
  <brief_title>Prolonged Treatment for Infected Abortion After Hospital Discharge.</brief_title>
  <acronym>APA</acronym>
  <official_title>Prolonged Treatment for Infected Abortion After Hospital Discharge.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with infected abortion will be treated with dilatation and curettage, intravenous
      antibiotics. The purpose of this study is to verify if it is necessary to keep the use of
      oral antibiotics after hospital discharge.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of 7-10 days of treatment for infected/septic abortion is not based on clinical
      trials. A recent evidence showed that endometritis post cesarean section needs no treatment
      after hospital discharge. The objective of this study is to verify if this finding also
      applies to infected abortions.

      After in hospital treatment, the patients will be randomized to the traditional treatment
      (metronidazole and doxycycline) or to placebo until 10 days of treatment is completed. Active
      follow-up will be done every 2 days, and the patient will be reevaluated at the end of
      treatment.

      Cure will be defined as the absence of fever, pain and bleeding. Failure of treatment will be
      considered as the need for hospitalization or additional antibiotics.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The rate of cure in both arms was higher than expected
  </why_stopped>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital re-admission</measure>
    <time_frame>7 days after hospital discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>minimal or absent vaginal bleeding</measure>
    <time_frame>7 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>walking normally</measure>
    <time_frame>7 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>important decrease of pain</measure>
    <time_frame>7 days after hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>no fever</measure>
    <time_frame>7 days after hospital discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Septic Abortion</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of antibiotics after hospital discharge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Use of placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>metronidazole and doxycycline</intervention_name>
    <description>use of metronidazole 500mg/day and doxycycline 200mg/day up to 10 days</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of intrauterine manipulation with contaminated objects.

          -  Vaginal secretion with fetid odor

          -  Presence of pus flowing through the cervical uterine

          -  Presence of peritonitis

          -  Leucocytosis (&gt; 14,000 leucocytes/mL)

          -  Vasodilatation, bounding pulse and paradoxically warm periphery with tachycardia
             (Heart rate&gt; 110 bpm)

          -  Cyanosis and/or paleness

          -  tachypnea(&gt; 30mpm)

          -  Arterial hypotension (SAP&lt; 90mmHg)

          -  Oliguria

          -  Fever (&gt; or = than 37,8°C)

        Exclusion Criteria:

          -  Refusal to participate in the project

          -  Prior use of antibiotics within one week

          -  Known allergy to Doxycycline or Metronidazole

          -  Presence of tubo-ovarian abscess
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo F Savaris, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Clínicas de Porto Alegre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adriani O Galão, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Clínicas de Porto Alegre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de Clínicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <zip>90035-003</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Clínicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90035-003</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Stubblefield PG, Grimes DA. Septic abortion. N Engl J Med. 1994 Aug 4;331(5):310-4. Review.</citation>
    <PMID>8022443</PMID>
  </reference>
  <reference>
    <citation>Tamussino K. Postoperative infection. Clin Obstet Gynecol. 2002 Jun;45(2):562-73. Review.</citation>
    <PMID>12048413</PMID>
  </reference>
  <reference>
    <citation>Turnquest MA, How HY, Cook CR, O'Rourke TP, Cureton AC, Spinnato JA, Brown HL. Chorioamnionitis: is continuation of antibiotic therapy necessary after cesarean section? Am J Obstet Gynecol. 1998 Nov;179(5):1261-6.</citation>
    <PMID>9822512</PMID>
  </reference>
  <reference>
    <citation>Faro S. Postpartum endometritis. Clin Perinatol. 2005 Sep;32(3):803-14. Review.</citation>
    <PMID>16085035</PMID>
  </reference>
  <reference>
    <citation>French LM, Smaill FM. Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001067. Review. Update in: Cochrane Database Syst Rev. 2015;2:CD001067.</citation>
    <PMID>15495005</PMID>
  </reference>
  <reference>
    <citation>Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001 Apr 17;134(8):663-94. Review.</citation>
    <PMID>11304107</PMID>
  </reference>
  <reference>
    <citation>Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999 Sep 11;319(7211):670-4. Review.</citation>
    <PMID>10480822</PMID>
  </reference>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2006</study_first_submitted>
  <study_first_submitted_qc>September 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2006</study_first_posted>
  <last_update_submitted>March 10, 2008</last_update_submitted>
  <last_update_submitted_qc>March 10, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 13, 2008</last_update_posted>
  <responsible_party>
    <name_title>Ricardo Francalacci Savaris</name_title>
    <organization>Hospital de Clínicas de Porto Alegre</organization>
  </responsible_party>
  <keyword>Abortion</keyword>
  <keyword>Infection</keyword>
  <keyword>Antibiotics</keyword>
  <keyword>Treatment</keyword>
  <keyword>Pregnancy complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Doxycycline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

